Publications of Sonja Horstmann

Journal Article (45)

1.
Journal Article
Hennings, J. M.; Kohli, M. A.; Czamara, D.; Giese, M.; Eckert, A.; Wolf, C.; Heck, A.; Domschke, K.; Arolt, V.; Baune, B. T. et al.: Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach. PLOS ONE 8 (6), e64947 (2013)
2.
Journal Article
Hennings, J. M.; Kohli, M. A.; Czamara, D.; Wolf, C.; Domschke, K.; Arolt, V.; Baune, T.; Horstmann, S.; Brückl, T.; Klengel, T. et al.: BDNF and NTRK2 polymorphisms and antidepressant treatment outcome. Pharmacopsychiatry 44 (6), p. 295 - 295 (2011)
3.
Journal Article
Hennings, J. M.; Kohli, M. A.; Czamara, D.; Heck, A.; Domschke, K.; Arolt, V.; Baune, B.; Horstmann, S.; Brueckl, T.; Klengel, T. et al.: BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 69 (9 Suppl.1), p. 152 S - 152 S (2011)
4.
Journal Article
Horstmann, S.; Binder, E. B.: Glucocorticoids as Predictors of Treatment Response in Depression. Harvard Review of Psychiatry 19 (3), pp. 125 - 143 (2011)
5.
Journal Article
Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), pp. 736 - 747 (2010)
6.
Journal Article
Hennings, J. M.; Kohli, M. A.; Heck, A.; Roeske, D.; Horstmann, S.; Brückl, T.; Klengel, T.; Menke, A.; Müller-Myhsok, B.; Ising, M. et al.: Polymorphisms in the BDNF Gene are Associated with Antidepressant Treatment Response. Biological Psychiatry 67 (9 Suppl.1), pp. 127S - 128S (2010)
7.
Journal Article
Horstmann, S.; Ising, M.; Adena, S.; Pfenning, A.; Modell, S.; Bettecken, T.; Müller-Myhsole, B.; Holsboer, F.; Binder, E. B.: Fine-Mapping of Genetic Loci Linked to REM-Density in the Munich Vulnerability Study. Biological Psychiatry 67 (9 Suppl.1), p. 128S - 128S (2010)
8.
Journal Article
Liu, J. Z.; Tozzi, F.; Waterworth, D. M.; Pillai, S. G.; Muglia, P.; Middleton, L.; Berrettini, W.; Knouff, C. W.; Yuan, X.; Waeber, G. et al.: Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics 42 (5), pp. 436 - 440 (2010)
9.
Journal Article
Kohli, M. A.; Salyakina, D.; Pfennig, A.; Lucae, S.; Horstmann, S.; Menke, A.; Kloiber, S.; Hennings, J.; Bradley, B. B.; Ressler, K. J. et al.: Association of Genetic Variants in the Neurotrophic Receptor-Encoding Gene NTRK2 and a Lifetime History of Suicide Attempts in Depressed Patients. Archives of General Psychiatry 67 (4), pp. 348 - 359 (2010)
10.
Journal Article
Horstmann, S.; Menke, A.; Straub, V.; Hennings, J.; Lucae, S.; Wollweber, S.; Binder, E. B.: Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. European Neuropsychopharmacology 20 (Suppl. 1), pp. S15 - S16 (2010)
11.
Journal Article
Horstmann, S.; Lucae, S.; Menke, A.; Hennings, J. M.; Ising, M.; Roeske, D.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment. Neuropsychopharmacology 35 (3), pp. 727 - 740 (2010)
12.
Journal Article
Lucae, S.; Ising, M.; Horstmann, S.; Baune, B. T.; Arolt, V.; Müller-Myhsok, B.; Holsboer, F.; Domschke, K.: HTR2A gene variation is involved in antidepressant treatment response. European Neuropsychopharmacology 20 (1), pp. 65 - 68 (2010)
13.
Journal Article
Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J.; Horstmann, S.; Kloiber, S. et al.: Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 73, pp. 665 - 666 (2009)
14.
Journal Article
Horstmann, S.; Binder, E. B.: Pharmacogenomics of antidepressant drugs. Pharmacology & Therapeutics 124 (1), pp. 57 - 73 (2009)
15.
Journal Article
Hennings, J. M.; Owashi, T.; Binder, E. B.; Horstmann, S.; Menke, A.; Kloiber, S.; Messer, T.; Pollmächer, T.; Nickel, T.; Sonntag, A. et al.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 42 (5), p. 222 - 222 (2009)
16.
Journal Article
Horstmann, S.; Menke, A.; Hennings, J. M.; Lucae, S.; Straub, V.; Spieler, D.; Wollweber, B.; Holsboer, F.; Binder, E. B.: Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 42 (5), p. 223 - 223 (2009)
17.
Journal Article
Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.: A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 66 (9), pp. 966 - 975 (2009)
18.
Journal Article
Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 42 (5), p. 224 - 224 (2009)
19.
Journal Article
Kloiber, S.; Kohli, M. A.; Brückl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)
20.
Journal Article
Horstmann, S.; Menke, A.; Hennings, J.; Straub, V.; Lucae, S.; Holsboer, F.; Binder, E.: Association of the Adrenergic Receptor Alpha l B with Antidepressant Treatment in the MARS Study. Biological Psychiatry 65 (8 Suppl. S), p. 230S - 230S (2009)